Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt–Jakob disease
Authors:
- 14 November 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 55 (9) , 1396-1398
Abstract
Article abstract The definitive diagnosis of Creutzfeldt–Jakob disease (CJD) requires brain tissue analysis. A positive assay for the 14-3-3 protein in CSF has been suggested to be highly sensitive and specific in patients with CJD. The authors describe three patients for whom CSF 14-3-3 assays were falsely positive or falsely negative. Caution against overreliance on this putative biomarker is suggested in the diagnosis of CJD.Keywords
This publication has 7 references indexed in Scilit:
- How to improve the clinical diagnosis of Creutzfeldt–Jakob diseaseBrain, 1999
- Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disordersAnnals of Neurology, 1999
- Abnormal Diffusion-Weighted Magnetic Resonance Images in Creutzfeldt-Jakob DiseaseArchives of Neurology, 1999
- Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob diseaseAnnals of Neurology, 1998
- Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agentNature, 1997
- The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform EncephalopathiesNew England Journal of Medicine, 1996
- Human prion diseasesAnnals of Neurology, 1994